Press Releases March 31, 2026 08:00 PM

Parsons to Announce First Quarter 2026 Financial Results on April 29, 2026

Parsons Corporation schedules Q1 2026 earnings release and conference call for April 29, 2026.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
PSN

Parsons Corporation announced it will release its first quarter 2026 financial results before market open on April 29, 2026, followed by a conference call to discuss earnings and guidance. The company operates in national security and global infrastructure markets and offers a webcast and replay of the call.

Parsons to Announce First Quarter 2026 Financial Results on April 29, 2026
PSN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Parsons Corporation will release Q1 2026 earnings on April 29, 2026.
  • A conference call and webcast will be held to discuss the results and guidance.
  • Parsons operates in national security, infrastructure, cyber warfare, and related sectors.

CHANTILLY, Va., April 01, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) will release first quarter 2026 financial results before the markets open on Wednesday, April 29, 2026. The company will host a conference call at 8:00 a.m. Eastern Time that day to discuss its earnings results and guidance, followed by a question-and-answer session.

Access to a webcast of the live conference call can be obtained through the Investor Relations section of the company's website (https://investors.parsons.com). Those parties interested in participating via telephone may register on the Investor Relations website or by clicking here.

A replay will be available on the company's website approximately two hours after the conference call and continuing for one year.

About Parsons Corporation

Parsons (NYSE: PSN) is a leading disruptive technology provider in the national security and global infrastructure markets, with capabilities across cyber and electronic warfare, space and missile defense, transportation, water and environment, urban development, and critical infrastructure protection. Please visit Parsons.com and follow us on LinkedIn to learn how we’re making an impact.

Contacts:   MediaInvestor RelationsBernadette MillerDave SpilleParsons CorporationParsons Corporation+1 980.253.9781+1 [email protected]@Parsons.us  

Risks

  • Financial results may not meet market expectations causing stock volatility.
  • Uncertainties in national security and infrastructure project funding could impact performance.
  • General macroeconomic conditions may affect the company's business outlook.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026